Healthcare DIVE December 21, 2017
Shannon Muchmore

If done well, the recently announced string of vertical and horizontal integrations could lower costs across the board. The execution required to achieve that, however, is complex and takes time.

December saw a flurry of merger activity underscoring a sense of desperation within healthcare.

A string of high-profile and potentially industry-changing deals surfaced, a mix of vertical and horizontal integrations that could trickle down to smaller companies. If done well, they could lower costs across the board. The execution required to achieve that, however, is complex and takes time.

It started with a bang on Dec. 3 when CVS Health announced a bid for Aetna in a blockbuster $69 billion deal.

A day later, Advocate Health Care and Aurora...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Mergers & Acquisitions / JV, Payer, Retail care
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Halozyme abandons its €2bn pursuit of Evotec
M&A Cyber Success Depends on Communication, an Honest Evaluation of Each Side’s Strengths & Risks, and an Open Mind
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
Weekly HCRE Briefing: AdventHealth to Acquire Two CHS Hospitals in FL | Kaiser Acquiring ASCs and MOBs

Share This Article